| Nov 8 |
Telesis Bio: Q3 Earnings Snapshot
|
| Sep 26 |
Telesis Bio partners with Danaher company Beckman Coulter
|
| Sep 25 |
Telesis Bio Stock Is Soaring Wednesday: What's Going On?
|
| Sep 25 |
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
|
| Sep 19 |
Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket
|
| Sep 12 |
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 11 |
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 10 |
Telesis Bio to delist its securities from Nasdaq
|
| Sep 10 |
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
|
| Aug 8 |
Telesis Bio GAAP EPS of -$7.62, revenue of $1.6M
|
